key: cord-0761394-vy3b2kgv
authors: Joob, Beuy; Wiwanitkit, Viroj
title: New COVID-19 Variant, VUI-202012/01: Molecular Change, Epitope Alteration, and Implication for Vaccine Efficacy
date: 2021-12-14
journal: Int J Prev Med
DOI: 10.4103/ijpvm.ijpvm_708_20
sha: 37bbe5d6c29e9a76bd031fb340b8ed1c79259f3d
doc_id: 761394
cord_uid: vy3b2kgv

nan

Here, the authors use a standard bioinformatics analysis, as used in previous reports, [1, 2] for assessing the effect of molecular change in the VUI-202012/01. The online tool is accessible via http://www.syfpeithi.de/bin/MHCServer. dll/EpitopePrediction.htm. According to the analysis, there is a change of epitope pattern. At the mutation part, the identified epitope sequence change from "487F Q P T N G V G Y" in naïve case to "515C G P K K S T N L" in VUI-202012/01. It might expect that the VUI-202012/01 will be the new problem to prevent the successful COVID-19 containment by the newly available COVID-19 vaccines.

Nil.

There are no conflicts of interest.

Epitope finding in 2019 novel coronavirus (2019-nCoV): The first world report

T cell epitopes within envelope glycoprotein of Ebola virus: The clue for vaccine development